NEW YORK (GenomeWeb News) – Luminex today announced that it has licensed its xMAP technology and the Luminex Bioscience Group’s assay development capabilities to Wageningen University and Research Center in the Netherlands.
 
Wageningen will use the xMAP multiplex technology for a variety of agricultural biotech areas including plant pathogen detection, epidemiology, food safety, and marker-assisted plant and animal breeding programs. Financial terms of the agreement were not disclosed.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.